DGAP-News: Aladdin Healthcare Technologies SE has developed a novel prototype application for more accurate real-time diagnosis of COVID-19 Corona Virus.
DGAP-News: Aladdin Healthcare Technologies SE
/ Key word(s): Product Launch
Aladdin Healthcare Technologies SE has developed a novel prototype application for more accurate real-time diagnosis of COVID-19 Corona Virus.
China and the world have been overwhelmed by the recent outbreak of a mutated version of the Coronavirus (COVID-19), which has resulted in unprecedented pressure on doctors, culminating in severe patient congestion and delayed diagnosis. As a solution, Aladdin will provide doctors with a real-time A.I application that can act as an assistive tool to make a more accurate diagnosis, thereby alleviating workload and diagnosing patients faster. It solves three major challenges to diagnose COVID-19: - It reduces the workload of doctors through the automatic generation of A.I assisted diagnosis reports in only 2-3 seconds instead of 5 to 6 hours. Distinguishing COVID-19 from other pulmonary diseases and healthy individuals at a very high degree of diagnostic accuracy. - Automatically detects and highlights lesion areas for COVID-19 and grades the disease severity in real time. The problem currently lies in the lack of a unified and rapid standard, especially in the core epidemic areas, which leads to inefficient manual diagnostic methods used by doctors for quantitative evaluation. The sudden and overwhelming medical needs in China have resulted in patient congestion accompanied by panic. Furthermore, it is difficult for doctors to rapidly distinguish the new Coronavirus from other pneumonia diseases by the only use of CT imaging (Computer Tomography scan). The Aladdin's method provides doctors with a new generation, real-time application, which assures a high accuracy in the disease diagnosis process. Aladdin's A.I solution is based on a multimodal approach that uses multi-omics data and CT image data. Through its advanced method, Aladdin can fight Coronavirus, saving time and improving diagnostic accuracy. "This is a great achievement for us. Based on this success, we have demonstrated our capability of providing accurate A.I solutions for complex diseases," said Wade Menpes-Smith, CEO of Aladdin Healthcare Technologies SE. "We have also been informed that the hospital group in Hangzhou wants to further expand the validation of our A.I model for the early detection of Alzheimer's Disease, cardiovascular disease and other diseases. This validates our tech and underpins our ability to execute on our plan about the 2020 milestones." About Aladdin Healthcare Technologies SE Website Link: www.aladdinid.com For further information Aladdin Healthcare Technologies Ltd. Contact Press
03.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Aladdin Healthcare Technologies SE |
Unter den Linden 10 | |
10117 Berlin | |
Germany | |
Phone: | 030 700140449 |
E-mail: | [email protected] |
Internet: | www.aladdinid.com |
ISIN: | DE000A12ULL2 |
WKN: | A12ULL |
Listed: | Regulated Market in Dusseldorf |
EQS News ID: | 988089 |
End of News | DGAP News Service |
|
988089 03.03.2020